Description: Benzyl benzoate -Human Insulin Analogue Glargine Inj 100 IU or ml Recombinant DNA origin 300 IU Disposable Pen with 5 needles per pen:Patient Care; Biphasic Isophane Insulin of 30 persent soluble Insuline and 70 percent Isophan Insulin Suspension 100 IU or ml 3 Ml Cartridge:Patient Care; Insulin Lispro Biphasic 50 percent of 50 percent Insulin Lispro and 50percent Insuline Lispro Protamine Suspension 100Iu or Ml and 3Ml Cartridge:Patient Care; Insulin Premixed Biphasic Human of 50percent Human Neutral 50percent Human Isophane Insulin of 10 Ml Inj:Patient Care; Erythropoietin Recombinant Human 5000 IU or 0 point 5 ml Inj:Patient Care;
Details: Human Insulin Analogue Glargine Inj 100 IU or ml Recombinant DNA origin 300 IU Disposable Pen with 5 needles per pen , Biphasic Isophane Insulin of 30 persent soluble Insuline and 70 percent Isophan Insulin Suspension 100 IU or ml 3 Ml Cartridge , Insulin Lispro Biphasic 50 Item Category/ percent of 50 percent Insulin Lispro and 50percent Insuline Lispro Protamine Suspension 100Iu or Ml and 3Ml Cartridge , Insulin Premixed Biphasic Human of 50percent Human Neutral 50percent Human Isophane Insulin of 10 Ml Inj , Erythropoietin Recombinant Human 5000 IU or 0 point 5 ml Inj Human Insulin Analogue Glargine Inj, 100 IU/ml (Recombinant DNA origin) 300 IU Disposable Pen with 5 needles per pen, Biphasic Isophane Insulin (30% Soluble Insuline & 70 % Isophan Insulin Suspension), 100 IU/ml, 3 Ml
Sector: Defense